In recent years, Johns Hopkins has been one of the leading research institutions exploring a class of drugs that were once considered taboo–namely psychedelics and hallucinogens. The Canadian Medical Association Journal recently analyzed a number of studies looking at psychedelic research at Hopkins and elsewhere. They found that the drugs show remarkable promise, and recommend that research should be increased.